Hirokazu Imai

3.5k citations
138 papers · 2.4k indexed · h-index 25
Topics
Renal Diseases and Glomerulopathies (48 papers)Amyloidosis: Diagnosis, Treatment, Outcomes (19 papers)Vasculitis and related conditions (13 papers)

In The Last Decade

Hirokazu Imai

133 papers receiving 2.4k citations

Peers

Hirokazu Imai
Comparison fields: 5 of 116
  • Nephrology 1.1k
  • Molecular Biology 623
  • Pulmonary and Respiratory Medicine 449
  • Immunology 376
  • Rheumatology 374
Replace Rezan Topaloğlu with:
Rezan Topaloğlu Türkiye
Jean‐Michel Goujon France
L Morel-Marogér France
Masayuki Endoh Japan
Hiroshi Kida Japan
Volker Vielhauer Germany
Benjamin H. Spargo United States
Naotake Tsuboi Japan
Winson W. Tang United States
Gloria R. Gallo United States
Hirokazu Imai relative to Rezan Topaloğlu Türkiye Rezan Topaloğlu's profile →
Citations per field
00.5×1.5×
Rezan Topaloğlu · 1×
Citations per year

Countries citing papers authored by Hirokazu Imai

Since Specialization
Citations

This map shows the geographic impact of Hirokazu Imai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirokazu Imai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirokazu Imai more than expected).

Fields of papers citing papers by Hirokazu Imai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hirokazu Imai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirokazu Imai. The network helps show where Hirokazu Imai may publish in the future.

Co-authorship network of co-authors of Hirokazu Imai

This figure shows the co-authorship network connecting the top 25 collaborators of Hirokazu Imai. A scholar is included among the top collaborators of Hirokazu Imai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hirokazu Imai. Hirokazu Imai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 23
2 5
3
[Secondary membranous nephropathy].
4
4 20
5 1
6 15
7 10
8 8
9 22
10 10
11 98
12 1
13 2
14 24
15 75
16 3
17 6
18 0
19 12
20 17

About Hirokazu Imai

Hirokazu Imai is a scholar working on Nephrology, Hematology and Genetics, having authored 138 papers that have together received 2.4k indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (48 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (19 papers) and Vasculitis and related conditions (13 papers). The work is most often cited by research in Nephrology (1.1k citations), Hematology (357 citations) and Rheumatology (374 citations). Hirokazu Imai has collaborated with scholars based in Japan, United States and Switzerland. Frequent co-authors include Akira Miura, Atsushi Komatsuda, Hiroshi Ohtani, Hideki Wakui, Yasushi Nakamoto, Tadashi Yasuda, Keiko Hamai, Naoto Miura, Nobuki Maki and K Sawada. Their work appears in journals such as Brain Research, Kidney International and The American Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026